Relation between process measures and diagnosis-specific readmission rates in patients with heart failure

Heart. 2015 Nov;101(21):1704-10. doi: 10.1136/heartjnl-2014-307328. Epub 2015 Jun 11.

Abstract

Objectives: To explore the relations between cause-specific readmission rates and National Heart Failure Audit process of care measures in patients admitted for heart failure (HF).

Methods: Using admissions data for all acute hospitals in England for April 2009-March 2012, we defined an index admission as the first emergency admission with a primary diagnosis of HF for at least three years. We compared risk-adjusted readmission rates for HF and for all non-HF diagnoses combined, risk-adjusted in-hospital mortality rates and performance on six Audit process measures.

Results: 14.7% of 123,644 patients died during the index admission. Of 105,441 index live discharges, 6853 (6.5%) were readmitted as emergencies within 7 days and 20,144 (19.1%) within 30 days. Index admission mortality rates correlated positively but weakly with non-HF readmission rates but not at all with HF rates. There was modest positive correlation at 7 days between HF and non-HF readmission rates (r=+0.24) but no significant relation at 30 or 365 days. All six process measures (prescribing of ACE inhibitors and beta-blockers, echocardiogram, cardiology inpatient and follow-up by cardiologist and HF liaison) correlated modestly but significantly with lower HF readmission rates at 7 days (r at most -0.26), only three did at 30 days and only cardiology follow-up did for non-HF at either 7 or 30 days; all associations were diminished at 365 days.

Conclusions: Hospitals scoring higher on evidence-based HF process measures had lower readmission rates, though the association seems limited to HF readmissions and is modest in strength and duration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Adult
  • Aged
  • Aged, 80 and over
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Echocardiography / statistics & numerical data
  • Emergency Service, Hospital / statistics & numerical data*
  • England / epidemiology
  • Female
  • Follow-Up Studies
  • Health Care Surveys
  • Heart Failure* / epidemiology
  • Heart Failure* / therapy
  • Hospital Mortality
  • Humans
  • Male
  • Medical Records, Problem-Oriented
  • Middle Aged
  • Outcome and Process Assessment, Health Care* / methods
  • Outcome and Process Assessment, Health Care* / statistics & numerical data
  • Patient Readmission / statistics & numerical data*
  • Time Factors

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors